OBJECTIVES: Patients with idiopathic REM sleep behavior disorder (IRBD) are at risk for developing Parkinson disease (PD) and dementia with Lewy bodies (DLB). We aimed to identify functional brain imaging patterns predicting the emergence of PD and DLB in patients with IRBD, using SPECT with (99m)Tc-ethylene cysteinate dimer (ECD). METHODS: Twenty patients with IRBD were scanned at baseline during wakefulness using (99m)Tc-ECD SPECT. After a follow-up of 3 years on average, patients were divided into 2 groups according to whether or not they developed defined neurodegenerative disease (PD, DLB). SPECT data analysis comparing regional cerebral blood flow (rCBF) between groups assessed whether specific brain perfusion patterns were associated with subsequent clinical evolution. Regression analysis between rCBF and clinical markers of neurodegeneration (motor, color vision, olfaction) looked for neural structures involved in this process. RESULTS: Of the 20 patients with IRBD recruited for this study, 10 converted to PD or DLB during the follow-up. rCBF at baseline was increased in the hippocampus of patients who would later convert compared with those who would not (p < 0.05 corrected). Hippocampal perfusion was correlated with motor and color vision scores across all IRBD patients. CONCLUSIONS: (99m)Tc-ECD SPECT identifies patients with IRBD at risk for conversion to other neurodegenerative disorders such as PD or DLB; disease progression in IRBD is predicted by abnormal perfusion in the hippocampus at baseline. Perfusion within this structure is correlated with clinical markers of neurodegeneration, further suggesting its involvement in the development of presumed synucleinopathies.
OBJECTIVES:Patients with idiopathic REM sleep behavior disorder (IRBD) are at risk for developing Parkinson disease (PD) and dementia with Lewy bodies (DLB). We aimed to identify functional brain imaging patterns predicting the emergence of PD and DLB in patients with IRBD, using SPECT with (99m)Tc-ethylene cysteinate dimer (ECD). METHODS: Twenty patients with IRBD were scanned at baseline during wakefulness using (99m)Tc-ECD SPECT. After a follow-up of 3 years on average, patients were divided into 2 groups according to whether or not they developed defined neurodegenerative disease (PD, DLB). SPECT data analysis comparing regional cerebral blood flow (rCBF) between groups assessed whether specific brain perfusion patterns were associated with subsequent clinical evolution. Regression analysis between rCBF and clinical markers of neurodegeneration (motor, color vision, olfaction) looked for neural structures involved in this process. RESULTS: Of the 20 patients with IRBD recruited for this study, 10 converted to PD or DLB during the follow-up. rCBF at baseline was increased in the hippocampus of patients who would later convert compared with those who would not (p < 0.05 corrected). Hippocampal perfusion was correlated with motor and color vision scores across all IRBD patients. CONCLUSIONS: (99m)Tc-ECD SPECT identifies patients with IRBD at risk for conversion to other neurodegenerative disorders such as PD or DLB; disease progression in IRBD is predicted by abnormal perfusion in the hippocampus at baseline. Perfusion within this structure is correlated with clinical markers of neurodegeneration, further suggesting its involvement in the development of presumed synucleinopathies.
Authors: Alex Iranzo; José Luis Molinuevo; Joan Santamaría; Mónica Serradell; María José Martí; Francesc Valldeoriola; Eduard Tolosa Journal: Lancet Neurol Date: 2006-07 Impact factor: 44.182
Authors: Alex Iranzo; Francisco Lomeña; Heike Stockner; Francesc Valldeoriola; Isabel Vilaseca; Manel Salamero; Jose Luis Molinuevo; Monica Serradell; Joan Duch; Javier Pavía; Judith Gallego; Klaus Seppi; Birgit Högl; Eduard Tolosa; Werner Poewe; Joan Santamaria Journal: Lancet Neurol Date: 2010-09-16 Impact factor: 44.182
Authors: Christoph Scherfler; Birgit Frauscher; Michael Schocke; Alex Iranzo; Viola Gschliesser; Klaus Seppi; Joan Santamaria; Eduardo Tolosa; Birgit Högl; Werner Poewe Journal: Ann Neurol Date: 2010-12-28 Impact factor: 10.422
Authors: Ronald B Postuma; Jean-François Gagnon; Mélanie Vendette; Catherine Desjardins; Jacques Y Montplaisir Journal: Ann Neurol Date: 2011-01-18 Impact factor: 10.422
Authors: Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael A Kilbourn; Roger L Albin; Kirk A Frey Journal: Brain Date: 2010-04-22 Impact factor: 13.501
Authors: B F Boeve; M H Silber; C B Saper; T J Ferman; D W Dickson; J E Parisi; E E Benarroch; J E Ahlskog; G E Smith; R C Caselli; M Tippman-Peikert; E J Olson; S-C Lin; T Young; Z Wszolek; C H Schenck; M W Mahowald; P R Castillo; K Del Tredici; H Braak Journal: Brain Date: 2007-04-05 Impact factor: 13.501
Authors: Florian Holtbernd; Jean-François Gagnon; Ron B Postuma; Yilong Ma; Chris C Tang; Andrew Feigin; Vijay Dhawan; Mélanie Vendette; Jean-Paul Soucy; David Eidelberg; Jacques Montplaisir Journal: Neurology Date: 2014-01-22 Impact factor: 9.910
Authors: Yves Dauvilliers; Carlos H Schenck; Ronald B Postuma; Alex Iranzo; Pierre-Herve Luppi; Giuseppe Plazzi; Jacques Montplaisir; Bradley Boeve Journal: Nat Rev Dis Primers Date: 2018-08-30 Impact factor: 52.329